Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2018-10-01
2019-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coenzyme Q10 in Relation to the Antioxidative Vitamins, Oxidative Stress and Inflammation in Coronary Artery Disease Patients During Statin Therapy
NCT01424761
Benefit of CoQ-10 in Patients on Statins
NCT00997269
The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia
NCT02407548
The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy
NCT00113477
Does Coenzyme Q 10 Supplementation Reduce Muscle Pain Caused by Statins? (Cholesterol Lowering Medications)
NCT00716612
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coenzyme Q10
2 pills of 150 mg CoQ10 phytosome (i.e. 300 mg CoQ10 phytosome per day)
Coenzyme Q10
2 pills/day of 150 mg CoQ10 phytosome (i.e. 300 mg CoQ10 phytosome per day)
Placebo
2 pills of placebo per day
Placebo
2 pills/day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coenzyme Q10
2 pills/day of 150 mg CoQ10 phytosome (i.e. 300 mg CoQ10 phytosome per day)
Placebo
2 pills/day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* treatment for \>6 months with statin monotherapy (i.e. enrolled individuals were asked to be on the same statin at the same dosage for \>6 months)
* statin-associated asthenia for \>3 months
Exclusion Criteria
* orthopedic disorders, myopathies and any other acute or chronic disease that could significantly affect the individual's perception of asthenia
* obesity (body mass index (BMI)\> 30 Kg/m2)
* known gastrointestinal disorders potentially affecting the absorption of CoQ10
65 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudio Borghi
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudio Borghi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Bologna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Bologna
Bologna, BO, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QELD_Stat_2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.